Click for best price
Kidney Fibrosis Drugs Market Size, Share 2024
The global Kidney Fibrosis Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Angiotensin Converting Enzyme (ACE) Inhibitors Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Kidney Fibrosis Drugs include Merck and Co, Galectin Therapeutics, Pfizer Inc, InterMune Inc, La Jolla Pharmaceutical Company, BioLine Rx, F. Hoffman-La Roche, ProMetic Life-Sciences Inc and Genzyme Corporation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Kidney Fibrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Fibrosis Drugs. This report contains market size and forecasts of Kidney Fibrosis Drugs in global, including the following market information:
Global Kidney Fibrosis Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Kidney Fibrosis Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Kidney Fibrosis Drugs companies in 2023 (%)
We has surveyed the Kidney Fibrosis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Fibrosis Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Kidney Fibrosis Drugs Market Segment Percentages, by Type, 2023 (%)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Global Kidney Fibrosis Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Kidney Fibrosis Drugs Market Segment Percentages, by Application, 2023 (%)
Chronic Kidney Diseases
Kidney Cancer Treatment
Others
Global Kidney Fibrosis Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Kidney Fibrosis Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Fibrosis Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Kidney Fibrosis Drugs revenues share in global market, 2023 (%)
Key companies Kidney Fibrosis Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Kidney Fibrosis Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck and Co
Galectin Therapeutics
Pfizer Inc
InterMune Inc
La Jolla Pharmaceutical Company
BioLine Rx
F. Hoffman-La Roche
ProMetic Life-Sciences Inc
Genzyme Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney Fibrosis Drugs, market overview.
Chapter 2: Global Kidney Fibrosis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Kidney Fibrosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Fibrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Kidney Fibrosis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Kidney Fibrosis Drugs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Kidney Fibrosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Fibrosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Fibrosis Drugs Overall Market Size
2.1 Global Kidney Fibrosis Drugs Market Size: 2023 VS 2030
2.2 Global Kidney Fibrosis Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Kidney Fibrosis Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Kidney Fibrosis Drugs Players in Global Market
3.2 Top Global Kidney Fibrosis Drugs Companies Ranked by Revenue
3.3 Global Kidney Fibrosis Drugs Revenue by Companies
3.4 Global Kidney Fibrosis Drugs Sales by Companies
3.5 Global Kidney Fibrosis Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Kidney Fibrosis Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Kidney Fibrosis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Fibrosis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Kidney Fibrosis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney Fibrosis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Kidney Fibrosis Drugs Market Size Markets, 2023 & 2030
4.1.2 Angiotensin Converting Enzyme (ACE) Inhibitors
4.1.3 Pirfenidone
4.1.4 Renin Inhibitors
4.1.5 Angiotensin II Receptor Blockers (ARBs)
4.1.6 Vasopeptidase Inhibitors
4.2 By Type - Global Kidney Fibrosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Kidney Fibrosis Drugs Revenue, 2019-2024
4.2.2 By Type - Global Kidney Fibrosis Drugs Revenue, 2025-2030
4.2.3 By Type - Global Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Kidney Fibrosis Drugs Sales & Forecasts
4.3.1 By Type - Global Kidney Fibrosis Drugs Sales, 2019-2024
4.3.2 By Type - Global Kidney Fibrosis Drugs Sales, 2025-2030
4.3.3 By Type - Global Kidney Fibrosis Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Kidney Fibrosis Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Fibrosis Drugs Market Size, 2023 & 2030
5.1.2 Chronic Kidney Diseases
5.1.3 Kidney Cancer Treatment
5.1.4 Others
5.2 By Application - Global Kidney Fibrosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Kidney Fibrosis Drugs Revenue, 2019-2024
5.2.2 By Application - Global Kidney Fibrosis Drugs Revenue, 2025-2030
5.2.3 By Application - Global Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Kidney Fibrosis Drugs Sales & Forecasts
5.3.1 By Application - Global Kidney Fibrosis Drugs Sales, 2019-2024
5.3.2 By Application - Global Kidney Fibrosis Drugs Sales, 2025-2030
5.3.3 By Application - Global Kidney Fibrosis Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Kidney Fibrosis Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Kidney Fibrosis Drugs Market Size, 2023 & 2030
6.2 By Region - Global Kidney Fibrosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Kidney Fibrosis Drugs Revenue, 2019-2024
6.2.2 By Region - Global Kidney Fibrosis Drugs Revenue, 2025-2030
6.2.3 By Region - Global Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Kidney Fibrosis Drugs Sales & Forecasts
6.3.1 By Region - Global Kidney Fibrosis Drugs Sales, 2019-2024
6.3.2 By Region - Global Kidney Fibrosis Drugs Sales, 2025-2030
6.3.3 By Region - Global Kidney Fibrosis Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Kidney Fibrosis Drugs Revenue, 2019-2030
6.4.2 By Country - North America Kidney Fibrosis Drugs Sales, 2019-2030
6.4.3 US Kidney Fibrosis Drugs Market Size, 2019-2030
6.4.4 Canada Kidney Fibrosis Drugs Market Size, 2019-2030
6.4.5 Mexico Kidney Fibrosis Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Kidney Fibrosis Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Kidney Fibrosis Drugs Sales, 2019-2030
6.5.3 Germany Kidney Fibrosis Drugs Market Size, 2019-2030
6.5.4 France Kidney Fibrosis Drugs Market Size, 2019-2030
6.5.5 U.K. Kidney Fibrosis Drugs Market Size, 2019-2030
6.5.6 Italy Kidney Fibrosis Drugs Market Size, 2019-2030
6.5.7 Russia Kidney Fibrosis Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Kidney Fibrosis Drugs Market Size, 2019-2030
6.5.9 Benelux Kidney Fibrosis Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Kidney Fibrosis Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Kidney Fibrosis Drugs Sales, 2019-2030
6.6.3 China Kidney Fibrosis Drugs Market Size, 2019-2030
6.6.4 Japan Kidney Fibrosis Drugs Market Size, 2019-2030
6.6.5 South Korea Kidney Fibrosis Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Kidney Fibrosis Drugs Market Size, 2019-2030
6.6.7 India Kidney Fibrosis Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Kidney Fibrosis Drugs Revenue, 2019-2030
6.7.2 By Country - South America Kidney Fibrosis Drugs Sales, 2019-2030
6.7.3 Brazil Kidney Fibrosis Drugs Market Size, 2019-2030
6.7.4 Argentina Kidney Fibrosis Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Kidney Fibrosis Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Kidney Fibrosis Drugs Sales, 2019-2030
6.8.3 Turkey Kidney Fibrosis Drugs Market Size, 2019-2030
6.8.4 Israel Kidney Fibrosis Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Kidney Fibrosis Drugs Market Size, 2019-2030
6.8.6 UAE Kidney Fibrosis Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck and Co
7.1.1 Merck and Co Company Summary
7.1.2 Merck and Co Business Overview
7.1.3 Merck and Co Kidney Fibrosis Drugs Major Product Offerings
7.1.4 Merck and Co Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Merck and Co Key News & Latest Developments
7.2 Galectin Therapeutics
7.2.1 Galectin Therapeutics Company Summary
7.2.2 Galectin Therapeutics Business Overview
7.2.3 Galectin Therapeutics Kidney Fibrosis Drugs Major Product Offerings
7.2.4 Galectin Therapeutics Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Galectin Therapeutics Key News & Latest Developments
7.3 Pfizer Inc
7.3.1 Pfizer Inc Company Summary
7.3.2 Pfizer Inc Business Overview
7.3.3 Pfizer Inc Kidney Fibrosis Drugs Major Product Offerings
7.3.4 Pfizer Inc Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer Inc Key News & Latest Developments
7.4 InterMune Inc
7.4.1 InterMune Inc Company Summary
7.4.2 InterMune Inc Business Overview
7.4.3 InterMune Inc Kidney Fibrosis Drugs Major Product Offerings
7.4.4 InterMune Inc Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.4.5 InterMune Inc Key News & Latest Developments
7.5 La Jolla Pharmaceutical Company
7.5.1 La Jolla Pharmaceutical Company Company Summary
7.5.2 La Jolla Pharmaceutical Company Business Overview
7.5.3 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Major Product Offerings
7.5.4 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.5.5 La Jolla Pharmaceutical Company Key News & Latest Developments
7.6 BioLine Rx
7.6.1 BioLine Rx Company Summary
7.6.2 BioLine Rx Business Overview
7.6.3 BioLine Rx Kidney Fibrosis Drugs Major Product Offerings
7.6.4 BioLine Rx Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.6.5 BioLine Rx Key News & Latest Developments
7.7 F. Hoffman-La Roche
7.7.1 F. Hoffman-La Roche Company Summary
7.7.2 F. Hoffman-La Roche Business Overview
7.7.3 F. Hoffman-La Roche Kidney Fibrosis Drugs Major Product Offerings
7.7.4 F. Hoffman-La Roche Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.7.5 F. Hoffman-La Roche Key News & Latest Developments
7.8 ProMetic Life-Sciences Inc
7.8.1 ProMetic Life-Sciences Inc Company Summary
7.8.2 ProMetic Life-Sciences Inc Business Overview
7.8.3 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Major Product Offerings
7.8.4 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.8.5 ProMetic Life-Sciences Inc Key News & Latest Developments
7.9 Genzyme Corporation
7.9.1 Genzyme Corporation Company Summary
7.9.2 Genzyme Corporation Business Overview
7.9.3 Genzyme Corporation Kidney Fibrosis Drugs Major Product Offerings
7.9.4 Genzyme Corporation Kidney Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Genzyme Corporation Key News & Latest Developments
8 Global Kidney Fibrosis Drugs Production Capacity, Analysis
8.1 Global Kidney Fibrosis Drugs Production Capacity, 2019-2030
8.2 Kidney Fibrosis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Fibrosis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney Fibrosis Drugs Supply Chain Analysis
10.1 Kidney Fibrosis Drugs Industry Value Chain
10.2 Kidney Fibrosis Drugs Upstream Market
10.3 Kidney Fibrosis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney Fibrosis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Kidney Fibrosis Drugs in Global Market
Table 2. Top Kidney Fibrosis Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Kidney Fibrosis Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Kidney Fibrosis Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Kidney Fibrosis Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Kidney Fibrosis Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Kidney Fibrosis Drugs Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Kidney Fibrosis Drugs Product Type
Table 9. List of Global Tier 1 Kidney Fibrosis Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Fibrosis Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Kidney Fibrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Kidney Fibrosis Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Kidney Fibrosis Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Kidney Fibrosis Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Kidney Fibrosis Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Kidney Fibrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Kidney Fibrosis Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Kidney Fibrosis Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Kidney Fibrosis Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Kidney Fibrosis Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Kidney Fibrosis Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Kidney Fibrosis Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Kidney Fibrosis Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Kidney Fibrosis Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Kidney Fibrosis Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Kidney Fibrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Kidney Fibrosis Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Kidney Fibrosis Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Kidney Fibrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Kidney Fibrosis Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Kidney Fibrosis Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Kidney Fibrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Kidney Fibrosis Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Kidney Fibrosis Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Kidney Fibrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Kidney Fibrosis Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Kidney Fibrosis Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Kidney Fibrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Kidney Fibrosis Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Kidney Fibrosis Drugs Sales, (K Units), 2025-2030
Table 46. Merck and Co Company Summary
Table 47. Merck and Co Kidney Fibrosis Drugs Product Offerings
Table 48. Merck and Co Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck and Co Key News & Latest Developments
Table 50. Galectin Therapeutics Company Summary
Table 51. Galectin Therapeutics Kidney Fibrosis Drugs Product Offerings
Table 52. Galectin Therapeutics Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Galectin Therapeutics Key News & Latest Developments
Table 54. Pfizer Inc Company Summary
Table 55. Pfizer Inc Kidney Fibrosis Drugs Product Offerings
Table 56. Pfizer Inc Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Pfizer Inc Key News & Latest Developments
Table 58. InterMune Inc Company Summary
Table 59. InterMune Inc Kidney Fibrosis Drugs Product Offerings
Table 60. InterMune Inc Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. InterMune Inc Key News & Latest Developments
Table 62. La Jolla Pharmaceutical Company Company Summary
Table 63. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product Offerings
Table 64. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. La Jolla Pharmaceutical Company Key News & Latest Developments
Table 66. BioLine Rx Company Summary
Table 67. BioLine Rx Kidney Fibrosis Drugs Product Offerings
Table 68. BioLine Rx Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. BioLine Rx Key News & Latest Developments
Table 70. F. Hoffman-La Roche Company Summary
Table 71. F. Hoffman-La Roche Kidney Fibrosis Drugs Product Offerings
Table 72. F. Hoffman-La Roche Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. F. Hoffman-La Roche Key News & Latest Developments
Table 74. ProMetic Life-Sciences Inc Company Summary
Table 75. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product Offerings
Table 76. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. ProMetic Life-Sciences Inc Key News & Latest Developments
Table 78. Genzyme Corporation Company Summary
Table 79. Genzyme Corporation Kidney Fibrosis Drugs Product Offerings
Table 80. Genzyme Corporation Kidney Fibrosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Genzyme Corporation Key News & Latest Developments
Table 82. Kidney Fibrosis Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 83. Global Kidney Fibrosis Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 84. Global Kidney Fibrosis Drugs Production by Region, 2019-2024 (K Units)
Table 85. Global Kidney Fibrosis Drugs Production by Region, 2025-2030 (K Units)
Table 86. Kidney Fibrosis Drugs Market Opportunities & Trends in Global Market
Table 87. Kidney Fibrosis Drugs Market Drivers in Global Market
Table 88. Kidney Fibrosis Drugs Market Restraints in Global Market
Table 89. Kidney Fibrosis Drugs Raw Materials
Table 90. Kidney Fibrosis Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Kidney Fibrosis Drugs Downstream
Table 92. Kidney Fibrosis Drugs Downstream Clients in Global Market
Table 93. Kidney Fibrosis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Kidney Fibrosis Drugs Segment by Type in 2023
Figure 2. Kidney Fibrosis Drugs Segment by Application in 2023
Figure 3. Global Kidney Fibrosis Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Kidney Fibrosis Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Kidney Fibrosis Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Kidney Fibrosis Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Fibrosis Drugs Revenue in 2023
Figure 9. By Type - Global Kidney Fibrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Kidney Fibrosis Drugs Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Kidney Fibrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Kidney Fibrosis Drugs Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Kidney Fibrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Kidney Fibrosis Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 23. US Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 28. Germany Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 37. China Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Kidney Fibrosis Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Kidney Fibrosis Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Kidney Fibrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Kidney Fibrosis Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Kidney Fibrosis Drugs by Region, 2023 VS 2030
Figure 54. Kidney Fibrosis Drugs Industry Value Chain
Figure 55. Marketing Channels
